takeda

The cross-border acquisitions that JapanÆs pharmaceutical companies are announcing could be just what the doctor ordered, even though they come with hefty price tags.

Takeda's purchase of US oncology firm Millennium represents Japan's largest outbound pharmaceuticals acquisition, but shareholders and analysts are questioning the offer price.